AtriCure is targeting a 12%-14% revenue growth by 2026, attributing this projected momentum to ongoing innovation and significant clinical progress.

Kenvue surpassed quarterly estimates and revealed job cuts as part of its acquisition by Kimberly-Clark.

Medifast has set a revenue target of $270 million to $300 million for 2026, as the company undergoes a CEO transition and shifts its focus towards metabolic health.

Cineverse has outlined an ambitious revenue target of $115 million to $120 million for 2027, driven by strategic acquisitions and the integration of AI-driven platform technologies.

Medtronic announced a decrease in profit even as the company experienced higher revenue.

Analysts are advising investors to buy NVIDIA stock with conviction ahead of its upcoming Q4 earnings report.

Seanergy's stock has reached a nearly four-year high following a strong performance in its fourth-quarter earnings report and the addition of two newbuild vessels to its fleet.

The U.S. first-quarter GDP slowdown was less severe than initial estimates suggested.

This article provides an overview of analyst estimates and ratings for Expeditors International stock.